FDA Approves Unknown Drug — RISING

# FDA Approves Rising's Generic Drug Application Rising Pharmaceuticals received FDA approval for its abbreviated new drug application (ANDA077420) on January 27, 2009, expanding the company's generic portfolio and positioning it to capture market share in an increasingly competitive generic pharmaceuticals sector. The approval strengthens Rising's competitive standing and provides healthcare providers and patients with an additional cost-effective treatment alternative.